GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A <i>Streptococcus</i>
Group A <i>Streptococcus</i> (GAS) causes about 500,000 annual deaths globally, and no vaccines are currently available. The Group A Carbohydrate (GAC), conserved across all GAS serotypes, conjugated to an appropriate carrier protein, represents a promising vaccine candidate. Here, we ex...
| 出版年: | Vaccines |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
MDPI AG
2022-06-01
|
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2076-393X/10/7/1034 |
